Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neoplasms, Basal Cell × folfirinox × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Dermatologic 1

Conditions

Pancreatic Neoplasms 4 Neoplasms, Basal Cell 1 Localized Pancreatic Adenocarcinoma 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

methyl 5-aminolevulinate 1 folfirinox 1 Taxes 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Gemcitabine 1 Fluorouracil 1 Erlotinib Hydrochloride 1 BF-200 ALA 1 Aminolevulinic Acid 1 Albumin-Bound Paclitaxel 1 5-aminolevulinic acid hexyl ester 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06483555 2025-04-16

PANGEA

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Recruiting

DermatologicGastrointestinal

Pancreatic Neoplasms, Neoplasms, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡